TACE联合射频消融治疗原发性肝癌效果分析

doi:10.3969/j.issn.1672-5069.2017.06.035

Abstract

Wu Jinfeng,Bai Guodong,Cheng Rong. Combination of TACE and ultrasound-guided radiofrequency ablation in the treatment of patients with primary liver cancer[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2017, 20(6): 766-768.

References

[1] McMahon B,Block J,Block T,et al. Hepatitis-associated liver cancer:Gaps and opportunities to improve care. J Nat Cancer Inst,2016,108（4）:890-894.
[2] 朱艺伟,姚明解,薄亚聪,等. 淋巴细胞与单核细胞比值对原发性肝癌患者根治性切除术后预后的预测价值.郑州大学学报（医学版）,2017,52（2）:197-200.
[3] 李佳红,付娜,牛学敏,等. 573例原发性肝癌病因及临床特点分析.实用肝脏病杂志,2015,18（4）:399-402.
[4] Gulec SA. Y-90 Radiomicrosphere therapy for colorectal cancer liver metastases. Semin Nucl Med,2016,46（2）:126-134.
[5] 程洪涛,郭晨阳,黎海亮,等. TACE联合射频消融治疗原发性肝癌疗效的影响因素分析. 介入放射学杂志,2012,21（3）:216-219.
[6] 张金坤,王燕燕. 原发性肝癌发生机制及其治疗的研究进展. 中国药房,2015,26（29）:4171-4173.
[7] 陈飞,贺露露,王闪,等. 经肝动脉化疗栓塞术联合索拉非尼治疗原发性肝癌患者疗效与生存分析. 实用肝脏病杂志,2016,19（3）:356-357.
[8] 赵建国.介入栓塞联合精确放疗治疗原发性肝癌的临床效果及生活质量评价. 肝脏,2015,20（12）:991-993.
[9] 郑孝文,赵永福,唐哲,等. 超声引导下肝恶性肿瘤射频消融治疗的疗效及其影响因素. 中华肝脏病杂志,2016,24（1）:69-73.
[10] 艾宁,冀宏. TACE联合放疗治疗原发性肝癌的临床疗效. 中国老年学杂志,2015,35（21）:6144-6146.
[11] 严翔,付必莽,唐波,等. 射频消融术治疗原发性肝癌的临床研究进展. 肝胆胰外科杂志,2016,28（1）:87-89.
[12] 张世玺. B超联合CT下行射频消融术治疗原发性肝癌的临床效果观察. 中国综合临床,2014,30（7）:681-683.
[13] Hao Q,Wang L,Chen F,et a1．Percutaneous radioffequency ablation for treatment of giant cell tulTIOr of bone guided by real-time US fused with CT．J Med Ultrasonics,2014,41（2）：223-227.
[14] Cai K,Yang R,Chen H,et al. Simulation and visualization of liver cancer ablation focus in optical surgical navigation. J Med Syst,2016,40（1）:19.
[15] Jiang L,Yan L,Wen T,et al. Comparison of outcomes of hepatic resection and radiofrequency ablation for hepatocellular carcinoma patients with multifocal tumors meeting the Barcelona-clinic liver cancer stage A classification. J Am Coll Surg,2015,221（5）:951-961.

Combination of TACE and ultrasound-guided radiofrequency ablation in the treatment of patients with primary liver cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhu Yage, Liu Jinfeng.. Therapeutic efficacy of adenosine methionine and glycyrrhizin combination in treatment of patients with alcoholic cirrhosis and its effect on serum BGP levels [J]. Journal of Practical Hepatology, 2019, 22(6): 872-875.
[2]	Zhao Fangfang, Zhai Yongzhen, Feng Guohe. Efficacy and safety of autologous peripheral blood stem cell transplantation in patients with hepatitis B cirrhosis [J]. Journal of Practical Hepatology, 2019, 22(5): 700-703.
[3]	Liu Xing, Zhao Shuli, Zhang Dianlong. Effect of sevoflurane inhalation on hepatic ischemia-reperfusion injury in patients with primary liver cancer undergoing partial hepatectomy [J]. Journal of Practical Hepatology, 2019, 22(5): 728-731.
[4]	Zhang Zhicheng, Yuan Guangqi, Mo Chanjun. Impact of blood supply on efficacy of hepatic artery embolization in treatment of patients with hepatic hemangioma [J]. Journal of Practical Hepatology, 2019, 22(5): 736-739.
[5]	Pei Ying, Huang Feng, Yin Hongzhen, et al. Preliminary study on intestinal microecology in mice with xenograft hepatoma intervened by sodiumnorcantharidate [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 486-489.
[6]	Yan Lingling, Hu Donghui, Huang Yanfang. Influence of ademetionine combined with polyene phosphatidylcholine on clinical efficacy and laboratory index in patients with intrahepatic cholestasis of pregnancy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 530-533.
[7]	Dai Qingyun, Wang Rundong, Jia Weidong. Prediction of early tumor recurrence by predictive nutritional index in patients with hepatocellular carcinoma undergoing hepatectomy [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 561-564.
[8]	Cui Faqiang, Li Tao, Wang Zheng, et al. A pilot study on cetuximab and KRAS gene mutation in treatment of patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(4): 565-568.
[9]	Yang Fucun, Shang Huaixue, Gai Yonghao. Enhanced magnetic resonance imaging by gadolinium disodium sebacate in diagnosis of patients with focal liver lesions [J]. Journal of Practical Hepatology, 2019, 22(4): 577-580.
[10]	Yuan Chunhui, Li Chunyu, Li Hongli. Efficacy of pegylated interferon α -2b in the treatment of patients with serum HBeAg positive chronic hepatitis B [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 353-356.
[11]	Peng Xinjian, Xiao Yuhui, Xu Siding. Diagnostic value of diffusion-weighted magnetic resonance imaging in patients with radiation-induced liver injury with underlying hepatocelullar carcinoma [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 373-376.
[12]	Zhao Xiaoguang, Shi Yujie. Protective effect of reduced glutathione on liver function in patients with advanced primary liver cancer underwent transarterial chemoembolization [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 425-428.
[13]	Ma Xiaosu, Pei Renming Zhang Tingting. Comparison of magnetic resonance cholangiopancreatography with color Doppler ultrasound in diagnosis of patients with common bile duct stones [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(3): 433-436.
[14]	Li Ketian, Shen Mingge, Wang Fengrong, Hu Chunrong, Cao Yujie, Lu Peng. Impact of blood glucose levels on imaging quality of PET/CT examination in patients with primary liver cancer [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 256-259.
[15]	Wang Xiuqing, Ma Yanjun, Zhan Jinli. Efficacy of transcatheter arterial chemoembolization and ultrasound-guided microwave ablation in the treatment of patients with hepatocellular carcinoma at special sites [J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2019, 22(2): 260-263.